vNOTES sentinel lymph node biopsy and hysterectomy for endometrial cancer staging: perioperative outcomes from a consecutive series
Abstract
Objective: To evaluate the feasibility and perioperative safety of vaginal natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy with sentinel lymph node biopsy (SLNB) for surgical staging of endometrial neoplasia. Methods: We conducted a retrospective consecutive case series at a tertiary gynecologic oncology center between May 2024 and December 2025. All patients undergoing hysterectomy and SLNB for staging of suspected or confirmed early-stage endometrial neoplasia using the vNOTES approach were included. Demographic characteristics, operative parameters, conversions, and intra-and postoperative complications were recorded. Primary outcomes were feasibility-defined as completion of the procedure without conversion-, detection rate and perioperative safety. Secondary outcomes included operative time, blood loss, hospital stay, and factors influencing operative performance. Results: Thirty-six patients were included. Median age was 63 years (IQR 57-69) and median BMI was 30 kg/m² (IQR 27-36). The procedure was completed by vNOTES in 33 patients (89%), with 1 conversion to laparoscopy (3%) and 2 conversions to laparotomy (6%) for specimen extraction. Median operative time was 125 min (IQR 115-150). Median hospital stay was 1 day (IQR 1-2; range 1-21). Estimated blood loss was <100 mL in 69% of procedures. Intraoperative complications occurred in 4 patients (11%), all bladder injuries recognized and repaired intraoperatively. Bilateral detection rate was 89% and unilateral detection rate was 100%. Operative time did not differ significantly between the first 10 cases and the subsequent procedures (median 125 vs 120 min, p = 0.86). No variable was significantly associated with the occurrence of complications, and BMI was not associated with operative duration. Conclusion: vNOTES hysterectomy with SLNB for endometrial cancer staging is feasible and demonstrates acceptable perioperative morbidity in a consecutive series. Further studies are required to assess long-term oncologic outcomes.
Related
- Impact of inflammatory bowel disease on perioperative complications in patients undergoing hysterectomy.
- ASO Video Abstract: How to Deal with Median Arcuate Ligament during Pancreaticoduodenectomy? Management Strategies and Impact on Perioperative Outcomes
- Evaluating the efficacy of a novel endometrial receptivity test in improving pregnancy outcomes for Chinese in vitro fertilization patients: a single-center retrospective study
- Electroacupuncture improves endometrial receptivity and pregnancy outcomes in controlled ovarian hyperstimulation rats by restoring Per2 circadian rhythm.
- Impact of direct oral anticoagulant treatment on management and outcomes of patients with hip fractures by monitoring assays. A population-based study of a cohort from the Geriatric Perioperative Unit
BibTeX
@article{gaillard2026vnotes,
title = {{vNOTES sentinel lymph node biopsy and hysterectomy for endometrial cancer staging: perioperative outcomes from a consecutive series}},
author = {Thomas Gaillard and Simon Ganancia and Louna Mossino Diaz and Thomas Montassier and Helene Didelot and Maria Pellisé-Tintoré and Virginie Fourchotte and Katia Mahiou and Nicolas Pouget and Grégoire Miailhe and Claire Bonneau and F. Lecuru and E. Laas},
journal = {Journal of Gynecology Obstetrics and Human Reproduction},
year = {2026},
month = nov,
doi = {10.1016/j.jogoh.2026.103256},
url = {https://hal.science/hal-05865972v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - vNOTES sentinel lymph node biopsy and hysterectomy for endometrial cancer staging: perioperative outcomes from a consecutive series
AU - Thomas Gaillard
AU - Simon Ganancia
AU - Louna Mossino Diaz
AU - Thomas Montassier
AU - Helene Didelot
AU - Maria Pellisé-Tintoré
AU - Virginie Fourchotte
AU - Katia Mahiou
AU - Nicolas Pouget
AU - Grégoire Miailhe
AU - Claire Bonneau
AU - F. Lecuru
AU - E. Laas
PY - 2026
DA - 2026/11/16
JO - Journal of Gynecology Obstetrics and Human Reproduction
DO - 10.1016/j.jogoh.2026.103256
UR - https://hal.science/hal-05865972v1
AB - Objective: To evaluate the feasibility and perioperative safety of vaginal natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy with sentinel lymph node biopsy (SLNB) for surgical staging of endometrial neoplasia. Methods: We conducted a retrospective consecutive case series at a tertiary gynecologic oncology center between May 2024 and December 2025. All patients undergoing hysterectomy and SLNB for staging of suspected or confirmed early-stage endometrial neoplasia using the vNOTES approach were included. Demographic characteristics, operative parameters, conversions, and intra-and postoperative complications were recorded. Primary outcomes were feasibility-defined as completion of the procedure without conversion-, detection rate and perioperative safety. Secondary outcomes included operative time, blood loss, hospital stay, and factors influencing operative performance. Results: Thirty-six patients were included. Median age was 63 years (IQR 57-69) and median BMI was 30 kg/m² (IQR 27-36). The procedure was completed by vNOTES in 33 patients (89%), with 1 conversion to laparoscopy (3%) and 2 conversions to laparotomy (6%) for specimen extraction. Median operative time was 125 min (IQR 115-150). Median hospital stay was 1 day (IQR 1-2; range 1-21). Estimated blood loss was <100 mL in 69% of procedures. Intraoperative complications occurred in 4 patients (11%), all bladder injuries recognized and repaired intraoperatively. Bilateral detection rate was 89% and unilateral detection rate was 100%. Operative time did not differ significantly between the first 10 cases and the subsequent procedures (median 125 vs 120 min, p = 0.86). No variable was significantly associated with the occurrence of complications, and BMI was not associated with operative duration. Conclusion: vNOTES hysterectomy with SLNB for endometrial cancer staging is feasible and demonstrates acceptable perioperative morbidity in a consecutive series. Further studies are required to assess long-term oncologic outcomes.
SN - 2468-8495
SN - 2468-7847
ER -